Research Article

Construction and Characterization of a Novel Fusion Protein MG7-scFv/SEB against Gastric Cancer

Figure 5

DNA ladder after treating with MG7-scFv/SEB. Lane 1: 10  𝜇 g/mL MG7-scFv/SEB group; lane 2: 1.0  𝜇 g/mL MG7-scFv/SEB group; lane 3: 0.1  𝜇 g/mL MG7-scFv/SEB group; lane 4: normal sodium group.
121094.fig.005